Litcius/Paper detail

A novel biosensor for the monitoring of ovarian cancer tumor protein CA 125 in untreated human plasma samples using a novel nano-ink: a new platform for efficient diagnosis of cancer using paper based microfluidic technology

Arezoo Saadati, Soodabeh Hassanpour, Farnaz Bahavarnia, Mohammad Hasanzadeh

2020Analytical Methods46 citationsDOI

Abstract

Carcinoma antigen 125 (CA 125) has been recognized as a clinical glycoprotein/biomarker for the early-stage detection of ovarian cancer.

Topics & Concepts

Ovarian cancerBiosensorNano-CancerCancer researchHuman plasmaCancer detectionChemistryBiologyMedicineChromatographyMaterials scienceInternal medicineBiochemistryComposite materialBiosensors and Analytical DetectionAdvanced biosensing and bioanalysis techniquesAdvanced Biosensing Techniques and Applications
A novel biosensor for the monitoring of ovarian cancer tumor protein CA 125 in untreated human plasma samples using a novel nano-ink: a new platform for efficient diagnosis of cancer using paper based microfluidic technology | Litcius